WO2002046224A3 - Compositions et procedes relatifs a des genes et proteines specifiques des poumons - Google Patents
Compositions et procedes relatifs a des genes et proteines specifiques des poumons Download PDFInfo
- Publication number
- WO2002046224A3 WO2002046224A3 PCT/US2001/050687 US0150687W WO0246224A3 WO 2002046224 A3 WO2002046224 A3 WO 2002046224A3 US 0150687 W US0150687 W US 0150687W WO 0246224 A3 WO0246224 A3 WO 0246224A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptides
- compositions
- lung
- antagonists
- nucleic acids
- Prior art date
Links
- 210000004072 lung Anatomy 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 6
- 239000000556 agonist Substances 0.000 abstract 3
- 239000005557 antagonist Substances 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 238000012544 monitoring process Methods 0.000 abstract 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 210000005265 lung cell Anatomy 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002241730A AU2002241730A1 (en) | 2000-10-26 | 2001-10-26 | Compositions and methods relating to lung specific genes and proteins |
EP01988422A EP1355934A2 (fr) | 2000-10-26 | 2001-10-26 | Compositions et procedes relatifs a des genes et proteines specifiques des poumons |
JP2002547960A JP2004520821A (ja) | 2000-10-26 | 2001-10-26 | 肺特異的遺伝子およびタンパク質に関する組成物および方法 |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24346100P | 2000-10-26 | 2000-10-26 | |
US60/243,461 | 2000-10-26 | ||
US25205500P | 2000-11-20 | 2000-11-20 | |
US60/252,055 | 2000-11-20 | ||
US25249600P | 2000-11-22 | 2000-11-22 | |
US60/252,496 | 2000-11-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002046224A2 WO2002046224A2 (fr) | 2002-06-13 |
WO2002046224A3 true WO2002046224A3 (fr) | 2003-08-21 |
Family
ID=27399666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/050687 WO2002046224A2 (fr) | 2000-10-26 | 2001-10-26 | Compositions et procedes relatifs a des genes et proteines specifiques des poumons |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1355934A2 (fr) |
JP (1) | JP2004520821A (fr) |
AU (1) | AU2002241730A1 (fr) |
WO (1) | WO2002046224A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10254601A1 (de) * | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
AU2012233044B2 (en) * | 2002-11-22 | 2015-09-03 | Ganymed Pharmaceuticals Ag | Genetic products differentially expressed in tumors and the use thereof |
CA3169263A1 (fr) | 2012-11-13 | 2014-05-22 | Astellas Pharma Inc. | Agents de traitement de maladies cancereuses exprimant claudine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000008206A1 (fr) * | 1998-08-04 | 2000-02-17 | Diadexus Llc | Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons |
WO2001066751A2 (fr) * | 2000-03-08 | 2001-09-13 | Pharmacia & Upjohn Company | Nouveaux recepteurs couples aux proteines g |
-
2001
- 2001-10-26 WO PCT/US2001/050687 patent/WO2002046224A2/fr not_active Application Discontinuation
- 2001-10-26 EP EP01988422A patent/EP1355934A2/fr not_active Withdrawn
- 2001-10-26 AU AU2002241730A patent/AU2002241730A1/en not_active Abandoned
- 2001-10-26 JP JP2002547960A patent/JP2004520821A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000008206A1 (fr) * | 1998-08-04 | 2000-02-17 | Diadexus Llc | Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons |
WO2001066751A2 (fr) * | 2000-03-08 | 2001-09-13 | Pharmacia & Upjohn Company | Nouveaux recepteurs couples aux proteines g |
Non-Patent Citations (3)
Title |
---|
DATABASE EMBL [online] 10 April 1999 (1999-04-10), BATES, K.: "Human DNA sequence from clone RP1-231N13 on chromosome 6q22 contains GSSs", XP002231917, retrieved from EBI Database accession no. AL049613 * |
DATABASE EMBL [online] 4 September 1998 (1998-09-04), ADAMS MD ET AL.: "CIT-HSP-2379F9.TR CIT-HSP Homo sapiens genomic clone 2379F9, genomic survey sequence", XP002231918, retrieved from EBI Database accession no. AQ111660 * |
DATABASE GENBANK [online] 6 November 1998 (1998-11-06), GARDNER ET AL.: "Ser/Thr protein kinase (Plasmodium falciparum)", XP002231919, retrieved from NCBI Database accession no. AAC71910 (gi:3845228) * |
Also Published As
Publication number | Publication date |
---|---|
AU2002241730A1 (en) | 2002-06-18 |
EP1355934A2 (fr) | 2003-10-29 |
WO2002046224A2 (fr) | 2002-06-13 |
JP2004520821A (ja) | 2004-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002062945A3 (fr) | Compositions et techniques relatives a des genes et a des proteines specifiques du poumon | |
WO2002055735A3 (fr) | Compositions et methodes en rapport avec des genes et des proteines specifiques de la prostate | |
WO2002040672A3 (fr) | Compositions et methodes relatives a des genes et des proteines specifiques aux seins | |
WO2002064741A3 (fr) | Compositions et methodes concernant des genes et des proteines specifiques du sein | |
WO2002040673A3 (fr) | Compositions et methodes relatives a des genes et des proteines specifiques aux poumons | |
WO2002077232A3 (fr) | Compositions et methodes relatives a des genes et a des proteines specifiques du sein | |
WO2004053075A3 (fr) | Compositions, variants d'epissage et procedes relatifs a des genes et des proteines specifiques du sein | |
WO2002064788A3 (fr) | Compositions et procedes relatifs aux genes et aux proteines specifiques aux poumons | |
WO2002042463A3 (fr) | Compositions et procedes se rapportant a des genes et proteines specifiques a la prostate | |
WO2003066877A3 (fr) | Compositions et procedes se rapportant a des genes et proteines specifiques hepatiques | |
WO2002068645A3 (fr) | Compositions et procedes concernant des genes et des proteines specifiques pour le sein | |
WO2002039431A3 (fr) | Compositions et methodes relatives a des genes et des proteines specifiques de la prostate | |
WO2002042776A3 (fr) | Compositions contenant des genes et des proteines specifiques a la prostate, et methodes faisant appel a ces genes et proteines | |
WO2002046224A3 (fr) | Compositions et procedes relatifs a des genes et proteines specifiques des poumons | |
WO2002088375A3 (fr) | Compositions et procedes se rapportant aux genes et proteines specifiques au sein | |
WO2002066605A3 (fr) | Compositions et procedes relatifs a des genes et a des proteines specifiques du sein | |
WO2004052290A3 (fr) | Compositions, variants d'epissage et procedes concernant des genes et proteines specifiques du sein | |
WO2003020899A3 (fr) | Compositions et methodes relatives a des genes et proteines specifiques des poumons | |
WO2002068633A3 (fr) | Compositions et procedes concernant des genes et proteines specifiques aux poumons | |
WO2002048370A3 (fr) | Compositions et methodes associees a des genes et a des proteines specifiques du colon | |
WO2003020953A3 (fr) | Compositions et procedes concernant des genes et des proteines specifiques du colon | |
WO2002042329A3 (fr) | Compositions et methodes se rapportant a des genes prostatiques specifiques et a des proteines | |
WO2002042499A3 (fr) | Compositions et methodes relatives a des genes et des proteines specifiques a la prostate | |
WO2002077234A3 (fr) | Compositions et methodes se rapportant aux genes et aux proteines specifiques du colon | |
WO2002042460A3 (fr) | Compositions et procedes associes a des genes et a des proteines specifiques du colon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002547960 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001988422 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001988422 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001988422 Country of ref document: EP |